Register for our free email digests:
Investor group plans to take Chinese pharmaco Simcere private; finalized at $122mm.
- Generic Drugs
- OTC, Consumer
- Includes Contract
- Payment Includes Cash
- Partial Acquisition
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.